Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000905749 | SCV001050344 | likely benign | not provided | 2018-11-09 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000905749 | SCV005259294 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Ambry Genetics | RCV004935173 | SCV005610481 | uncertain significance | not specified | 2024-11-27 | criteria provided, single submitter | clinical testing | The c.3088G>A (p.G1030R) alteration is located in exon 18 (coding exon 18) of the LRIG2 gene. This alteration results from a G to A substitution at nucleotide position 3088, causing the glycine (G) at amino acid position 1030 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |